Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks
- Conditions
- Influenza, HumanInfluenzaInfluenza -Like Illness
- Interventions
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT05012189
- Locations
- πΊπΈ
Insight Therapeutics, LLC, Norfolk, Virginia, United States
Recombinant Influenza Vaccination in U.S. Nursing Homes
- Conditions
- Influenza, HumanInfluenza -Like IllnessInfluenza
- Interventions
- Biological: Recombinant Influenza VaccineBiological: Standard Dose Quadrivalent Influenza Vaccine
- First Posted Date
- 2019-05-28
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 1989
- Registration Number
- NCT03965195
- Locations
- πΊπΈ
Insight Therapeutics, LLC, Norfolk, Virginia, United States
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
- Conditions
- InfluenzaInfluenza-like IllnessInfluenza, Human
- Interventions
- Biological: Influenza
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 598
- Registration Number
- NCT03599739
- Locations
- πΊπΈ
Insight Therapeutics, LLC, Norfolk, Virginia, United States
A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting
- Conditions
- Urinary Incontinence
- Interventions
- Other: Care planning without using TENA Identifi sensor wear dataOther: Care planning using TENA Identifi sensor wear data
- First Posted Date
- 2017-07-06
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 49
- Registration Number
- NCT03209570
- Locations
- πΊπΈ
Chesapeake Health & Rehabilitation Center, Chesapeake, Virginia, United States
πΊπΈNorfolk Health & Rehabilitation Center, Norfolk, Virginia, United States
πΊπΈInsight Therapeutics, LLC, Norfolk, Virginia, United States
Immunogenicity of Influenza Vaccine in Long Term Care
- Conditions
- Influenza
- Interventions
- Procedure: Blood Draw
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2021-03-09
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 200
- Registration Number
- NCT02933723
- Locations
- πΊπΈ
Case Western Reserve University, Cleveland, Ohio, United States
Adjuvanted Influenza Vaccination in U.S. Nursing Homes
- Conditions
- Influenza-like IllnessInfluenza
- Interventions
- Biological: adjuvanted trivalent influenza vaccineBiological: trivalent influenza vaccine
- First Posted Date
- 2016-08-29
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 823
- Registration Number
- NCT02882100
- Locations
- πΊπΈ
Insight Therapeutics, LLC, Norfolk, Virginia, United States
High-Dose Influenza Vaccine in Nursing Homes
- Conditions
- Influenza
- Interventions
- Biological: SD VaccineBiological: HD VaccineBiological: Free VaccineBiological: Usual Care
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 823
- Registration Number
- NCT01815268
- Locations
- πΊπΈ
Brown University, Providence, Rhode Island, United States
πΊπΈCase Western Reserve University, Cleveland, Ohio, United States
πΊπΈInsight Therapeutics, LLC, Norfolk, Virginia, United States
High Dose Influenza Vaccine in Nursing Home - Pilot Study
- Conditions
- Influenza
- Interventions
- Biological: HD Fluzone VaccineBiological: SD Fluzone Vaccine
- First Posted Date
- 2012-11-02
- Last Posted Date
- 2018-05-23
- Lead Sponsor
- Insight Therapeutics, LLC
- Target Recruit Count
- 2957
- Registration Number
- NCT01720277
- Locations
- πΊπΈ
Brown Univeristy, Providence, Rhode Island, United States
πΊπΈInsight Therapeutics, Norfolk, Virginia, United States